Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study.
Fiche publication
Date publication
mai 2024
Journal
Surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Pr AYAV Ahmet, Pr BACHELLIER Philippe, Dr FACY Olivier
Tous les auteurs :
Addeo P, de Mathelin P, Doussot A, Durin T, Canali G, Marchese U, Sauvanet A, Dokmak S, Cherkaoui Z, Fuks D, Laurent C, André M, Ayav A, Magallon C, Turrini O, Sulpice L, Robin F, Bachellier P, Souche FR, Bardol T, Perinel J, Adham M, Tzedakis S, Birnbaum DJ, Facy O, Gagniere J, Gaujoux S, Tribillon E, Roussel E, Schwarz L, Barbier L, Regenet N, Iannelli A, Regimbeau JM, Piessen G, Truant S, El Amrani M
Lien Pubmed
Résumé
Minimally invasive surgery has gained momentum for left pancreatic resections. However, debate remains about whether it has any advantage over open surgery for distal pancreatectomy for pancreatic neuroendocrine tumors.
Référence
Surgery. 2024 05 25;: